Characterization of acute lymphoblastic leukemia subtypes in Brazilian patients

1996 ◽  
Vol 20 (4) ◽  
pp. 349-355 ◽  
Author(s):  
Eduardo M. Rego ◽  
Aglair B. Garcia ◽  
Sonia R. Viana ◽  
Roberto P. Falcão
2009 ◽  
Vol 221 (03) ◽  
Author(s):  
R Vagkopoulou ◽  
C Eckert ◽  
U Ungethüm ◽  
G Körner ◽  
M Stanulla ◽  
...  

Leukemia ◽  
2020 ◽  
Vol 34 (10) ◽  
pp. 2785-2789
Author(s):  
Peter Horak ◽  
Sebastian Uhrig ◽  
Maximilian Witzel ◽  
Irene Gil-Farina ◽  
Barbara Hutter ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Saleh A. Mohamed ◽  
Mohamed F. Elshal ◽  
Taha A. Kumosani ◽  
Alia M. Aldahlawi

L-asparaginase from bacteria has been used in treatment of acute lymphoblastic leukemia. The aim of this study was to purify and characterize L-asparaginase fromPhaseolus vulgarisseeds instead of microbial sources. L-asparaginase was purified to apparent homogeneity. The enzyme has molecular mass of 79 kDa. The purified asparaginase had very low activity toward a number of asparagine and glutamine analogues. L-asparaginase was free from glutaminase activity. Kinetic parameters, Km andVmax of purified enzyme, were found to be 6.72 mM and 0.16 μM, respectively. The enzyme had optimum pH at 8.0. The enzyme showed high stability at alkaline pH (pH 7.5–9.0) when incubated for up to 24 h. L-asparaginase had the same temperature optimum and thermal stability at 37°C. K+was able to greatly enhance the activity of asparaginase by 150% compared with other metals tested. In conclusion, L-asparaginase showed no glutaminase activity and good stability over a wide range of physiological conditions, and thus it could be used as a potential candidate for treatment of acute lymphoblastic leukemia.


1985 ◽  
Vol 9 (12) ◽  
pp. 1497-1506 ◽  
Author(s):  
L.J. Jenski ◽  
B.C. Lampkin ◽  
T.S. Goh ◽  
P. Dinndorf ◽  
D.A. Hake ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document